|Dr. Jochen Schmitz||CFO & Member of Management Board||770k||N/A||1966|
|Mr. Michael Reitermann||Chief Markets & Diagnostics Officer and Member of Management Board||825k||N/A||1962|
|Dr. Bernhard Montag||CEO & Member of Management Board||N/A||N/A||1969|
|Mr. Marc Koebernick||Head of Investor Relations||N/A||N/A||N/A|
|Mr. Michel Therin||Pres of Advanced Therapies||N/A||N/A||1961|
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services worldwide. The company's Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. Its Advanced Therapies segment produces integrated products, solutions, and services for therapy departments of healthcare providers. This segment's principal products include angiography systems and mobile C-arms. The company's Diagnostics segment offers diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics, including critical and chronic care. Siemens Healthineers AG also provides customer value chain services, including consulting, design, maintenance, operational management, training, and education services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Siemens Healthineers AG’s ISS Governance QualityScore as of October 4, 2019 is 5. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 1; Compensation: 3.